Back
Processa Pharmaceuticals, Inc. 10K Form
Sell
29
PCSA
Processa Pharmaceuticals, Inc.
Last Price:
$0.15
Seasonality Move:
-16.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PCSA News And Ratings
See the #1 stock for the next 7 days that we like better than PCSA
PCSA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.11 |
| Price / Book: | 2.62 |
Profitability
| EPS (TTM): | -1.36060 |
|---|---|
| Net Income (TTM): | $-12.9M |
| Gross Margin: | $-800 |
| Return on Equity: | -309.65% |
| Return on Assets: | -224.95% |
Processa Pharmaceuticals, Inc. Earnings Forecast
Key Processa Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Processa Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PCSA |
| Website: | processapharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.76 |
| Quick Ratio: | 3.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PCSA Technical Analysis vs Fundamental Analysis
Sell
29
Processa Pharmaceuticals, Inc. (PCSA)
is a Sell
Is Processa Pharmaceuticals, Inc. a Buy or a Sell?
-
Processa Pharmaceuticals, Inc. stock is rated a SellThe current Processa Pharmaceuticals, Inc. [PCSA] share price is $0.27. The Score for PCSA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.